Key result
Diabetes remains a potent CAD risk factor driving widespread microvascular and macrovascular complications.
This review highlights the extensive microvascular and macrovascular complications of diabetes mellitus and outlines potential therapeutic modalities to mitigate these risks.
Supports heightened CAD vigilance in diabetes care; leaves open optimal therapeutic targets for microvascular complications.
Diabetes mellitus (DM) is one of the most potent independent risk factors for the development of coronary ar- tery disease (CAD) and is recognized as a cardiovascular disease equivalent. Compared with individuals without DM, those with DM have a higher prevalence of CAD, a greater extent of coronary ischemia, and are more likely to have a myocardial infarction and silent myocardial ischemia. The vasculature of diabetic patients is more vulnerable in develop- ing atherosclerotic plaques in comparison with the vasculature of the non diabetic individuals. Microvascular and mac- rovascular effects are observed in the majority of organs of diabetic patients. Endothelial dysfunction, increased stiffness of the aorta, renal artery stenosis, diabetic nephropathy, carotid artery stenosis leading to cerebrovascular insufficiency, CAD and heart failure are the main complications of DM on the vasculature. Therapeutic modalities such as angiotensin- converting enzyme inhibitors, angiotensin II receptor blockers, thiazolidinediones (glitazones), statins, and antioxidants may be useful in these patients.
No takes yet. Share an insight, caveat, or question.
Kampoli et al. (2009) conducted a review in Diabetes mellitus. Diabetes mellitus vs. Individuals without diabetes mellitus was evaluated. Diabetes mellitus is a potent independent risk factor for coronary artery disease, leading to widespread microvascular and macrovascular complications compared with non-diabetic individuals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: